NCT03571308 2023-09-28ACCEPTUniversity Hospital Southampton NHS Foundation TrustPhase 1/2 Completed39 enrolled
NCT01992653 2023-03-14A Study of Polatuzumab Vedotin in Combination With Rituximab or Obinutuzumab, Cyclophosphamide, Doxorubicin, and Prednisone in Participants With B-Cell Non-Hodgkin's LymphomaGenentech, Inc.Phase 1/2 Completed85 enrolled 34 charts